Dear Colleague,

I would like to personally invite you to attend our upcoming virtual Pharma Progress 2021 event, Rare Diseases: Access All Areas – Opportunities and Implications for Rare Disease Patients, on Tuesday, November 9.

This event, presented by BresMed and Cello Health, will focus on the implications of rare diseases for patients and pharma and how we can support the development of treatments and care pathways which meet the needs of those living with rare diseases.

Key speakers include:

• Matthias Bischof, Senior Director, Global Health Economics and Outcomes Research, Novartis Gene Therapies
• Sharon Hesterlee, PhD, Executive Vice President & Chief Research Officer, Muscular Dystrophy Association
• Peter Jackson, PhD, FRCP, Chair NICE HST Committee
• Emily McGinnis, MPH, Chief Patient Officer and Head of Government Affairs, Taysha Gene Therapies
• Nick Sireau, CEO and Chair of Trustees, AKU Society

For additional information and to register for the event, please click here.

If you’d like to find out more directly, please don’t hesitate to contact me.

Thank you,

Michael Rice
Vice President, Head of Advanced Therapeutics